We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+3.53%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12B
AUM Growth
-$353M
(-2.9%)
Cap. Flow
-$617M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
12.46%
Holding
637
New
171
Increased
105
Reduced
150
Closed
191
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delta Air Lines
DAL
|
+$140M |
| 2 |
AbbVie
ABBV
|
+$119M |
| 3 |
KeyCorp
KEY
|
+$115M |
| 4 |
F5
FFIV
|
+$111M |
| 5 |
Walmart Inc
WMT
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$146M |
| 2 |
S&P Global
SPGI
|
+$142M |
| 3 |
Eli Lilly
LLY
|
+$133M |
| 4 |
Labcorp
LH
|
+$131M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.86% |
| 2 | Healthcare | 13.19% |
| 3 | Industrials | 12.91% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Financials | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
AnaptysBio
ANAB
$1.62B
| – | – |
-52,250
| Closed | -$1.45M |
|
452
A.O. Smith
AOS
$8.56B
| – | – |
-50,710
| Closed | -$2.59M |
|
453
Aptiv
APTV
$9.61B
| – | – |
-529,850
| Closed | -$42.6M |
|
454
Aramark
ARMK
$14.8B
| – | – |
-1,000,744
| Closed | -$26.6M |
|
|
ASRT
455
DELISTED
Assertio
ASRT
| – | – |
-4,942
| Closed | -$3.72M |
|
456
Best Buy
BBY
$16.9B
| – | – |
-992,303
| Closed | -$48.8M |
|
|
BLUE
457
DELISTED
bluebird bio
BLUE
| – | – |
-21,539
| Closed | -$25.4M |
|
|
BPMC
458
DELISTED
Blueprint Medicines
BPMC
| – | – |
-59,746
| Closed | -$2.39M |
|
459
Boston Scientific
BSX
$71.4B
| – | – |
-210,199
| Closed | -$5.23M |
|
460
Cboe Global Markets
CBOE
$30.2B
| – | – |
-319,228
| Closed | -$25.9M |
|
461
Celanese
CE
$4.82B
| – | – |
-250,253
| Closed | -$22.5M |
|
|
CHMI
462
Cherry Hill Mortgage Investment Corp
CHMI
$87.8M
| – | – |
-250,000
| Closed | -$4.27M |
|
463
C.H. Robinson
CHRW
$17.1B
| – | – |
-72,795
| Closed | -$5.63M |
|
464
Ciena
CIEN
$57.2B
| – | – |
-1,115,448
| Closed | -$26.3M |
|
465
Celestica
CLS
$36.2B
| – | – |
-1,321,095
| Closed | -$19.2M |
|
466
Costco
COST
$421B
| – | – |
-628,592
| Closed | -$105M |
|
467
Capri Holdings
CPRI
$1.72B
| – | – |
-210,000
| Closed | -$8M |
|
468
Camden Property Trust
CPT
$11B
| – | – |
-41,984
| Closed | -$3.38M |
|
469
CSX Corp
CSX
$93.9B
| – | – |
-1,481,409
| Closed | -$23M |
|
470
Dana Inc
DAN
$2.94B
| – | – |
-90,477
| Closed | -$1.75M |
|
471
Donnelley Financial Solutions
DFIN
$1.19B
| – | – |
-125,000
| Closed | -$2.41M |
|
472
Brinker International
EAT
$9.75B
| – | – |
-148,293
| Closed | -$6.52M |
|
473
e.l.f. Beauty
ELF
$5.44B
| – | – |
-100,000
| Closed | -$2.88M |
|
474
EPAM Systems
EPAM
$4.86B
| – | – |
-82,828
| Closed | -$6.25M |
|
475
Exelixis
EXEL
$13.1B
| – | – |
-768,346
| Closed | -$16.6M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2017 Portfolio in Review
As of Q2 2017, Alyeska Investment Group held 637 positions worth $12B, down 2.9% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Alyeska Investment Group withdrew a net $617M in Q2 2017, closing 191 positions and reducing 150 holdings. Its most notable exit was Eli Lilly, an estimated $133M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Alyeska Investment Group opened a new position in AbbVie worth $128M.
- Alyeska Investment Group's largest Q2 2017 buy was AbbVie: 1,771,895 shares worth $128M.
- Alyeska Investment Group added most to Delta Air Lines in Q2 2017, an estimated $140M increase.
- Alyeska Investment Group's biggest Q2 2017 reduction was Oracle, cutting an estimated $146M.
- Alyeska Investment Group fully exited Eli Lilly in Q2 2017, selling an estimated $133M.
- Alyeska Investment Group's ten largest holdings make up 12% of its $12B portfolio in Q2 2017.
- Alyeska Investment Group opened 171 new positions and closed 191 in Q2 2017.
- Alyeska Investment Group's portfolio value fell 2.9% quarter-over-quarter to $12B.
Based on Alyeska Investment Group's 13F filing for Q2 2017, filed 14 Aug 2017.